trans-4-Methoxycyclohexanamine hydrochloride, 97%, 10g

4-Hydroxybenzoic acid, min. 98%, for synthesis, 100 g, plastic packaging.

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(9R)-6'-methoxycinchonan-9-yl]thiourea, 99.06%, 1g

9-Decenoic acid, 90.0%, 5g

2,5-Dibromothiazole, 98.0%, 100g

Boc-D-Lys-OH, 98%, 5g

5-Amino-2-(trifluoromethyl)benzimidazole, 95.0%, 5g

Vacuum filter unit Steriflip®, 60 µm, nylon, 25 Piece(s)

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)

1-Benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid, 97.0%, 100mg

2-(Pyrrolidin-3-yloxy)pyrimidine hydrochloride, 1g

Methyl 5-amino-4-cyano-1H-pyrazole-1-carboxylate, 95.0%, 2g

8-Bromo-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one, 95+%, 500mg